Evolving Fields of Cardiac Resynchronization Therapy
On-Demand Audio Webcast
Sponsored by North American Center for Continuing Medical Education, LLC
Presenters
William T. Abraham, MD, FACP, FACC, FAHA
Professor of Medicine, Physiology, and Cell Biology
Director, Division of Cardiovascular Medicine
Deputy Director, Davis Heart and Lung Research Institute
The Ohio State University
Columbus, Ohio
Kenneth A. Ellenbogen, MD, PhD
Kontos Professor of Medicine
Chairman, Division of Cardiology
Virginia Commonwealth University School of Medicine
Richmond, Virginia
Michael Gold, MD, PhD
Michael E. Assey Professor of Medicine
Chief of Cardiology
Medical University of South Carolina
Charleston, South Carolina
Jagmeet P. Singh, MD, DPhil
Associate Professor of Medicine
Harvard Medical School
Cardiac Arrhythmia Service
Director, Cardiac Resynchronization Therapy Program
Massachusetts General Hospital Heart Center
Boston, Massachusetts
Johannes Holzmeister, MD
Director Cardiac Device Program
Cardiology
University Hospital Zurich
Zurich, Switzerland
Target Audience
This activity is designed for electrophysiologists, cardiologists, nurses and allied health professional who treat patients with cardiac arrhythmias.
Learning Objectives
After completing this activity, participants should be able to:
- Evaluate cardiac resynchronization therapy for the management of patients with mildly symptomatic heart failure
- Implement cardiac resynchronization therapy in patients with narrow QRS complexes
- Discus the relationship between electrical and mechanical cardiac dyssynchrony in heart failure patients.
Activity Overview
This on-demand audio webcast is available with synchronized slides and audio.
To be eligible for documentation of credit, participant must participate in the full activity, complete the post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.
There is no fee associated with this activity.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Release Date: July 1, 2010
Expiration Date: July 1, 2011
Estimated time to complete: 1.5 hours
For questions regarding this activity, please call 609-371-1137.
Hardware/Software Requirements
All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com. :
CME Accreditation
North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
NACCME designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE Accreditation
North American Center for Continuing Medical Education, LLC (NACCME) is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
This continuing nursing education activity was approved for 1.5 contact hours
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.5 contact hours.
AHRA Accreditation
Approved for 1.5 Category A, ARRT continuing education credits.
Independent Clinical Reviewer
Robert S. Dieter, MD, RVT
Loyola University Medical Center
Vascular and Endovascular Medicine
Interventional Cardiology
Assistant Professor of Medicine
Section of Cardiovascular Medicine
Maywood, Illinois
Planning Committee
The planning committee comprises William T. Abraham, MD, FACP, FACC, FAHA, Kenneth A. Ellenbogen, MD, PhD, Michael Gold, MD, PhD, Jagmeet P. Singh, MD, DPhil, Johannes Holzmeister, MD, Robert Dieter, MD; Rich Keenan, Trish Levy and Lindsay Mazzagatti, NACCME.
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Doctor Gold: grant/research support--Boston Scientific, Medtronic and St. Jude Medical.; Consultant--Boston Scientific and Medtronic; Scientific advisor--Sorin.
Dr. Ellenbogen: grant/research support-- Medtronic, Boston Scientific and St. Jude Medical; Consultant and scientific advisor--Medtronic, Boston Scientific, St. Jude Medical and Biotronik; Speakers bureau--Medtronic, Boston Scientific, St Jude Medical and Biotronik.; Employee/officer or board member--Boston Scientific.
Dr. Abraham: grant/research support from and is a consultant to BIOTRONIK, Boston Scientific, Medtronic, St. Jude Medical and Cardiomems
Dr. Singh: grant/research support and consultant—Biotronik, Boston Scientific, Medtronic and St Jude Medical.
Dr. Holzmeister: grant/research support from and is a consultant to BIOTRONIK
Dr. Dieter: no relevant financial relationship with any commercial interest.
Mr. Keenan, Ms. Levy and Ms. Mazzagatti have disclosed no relevant financial relationships with any commercial interests.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
The faculty has disclosed the following off-label/unapproved use(s) of drugs and/or devices will be discussed: The use of CRT for the treatment of NYHA I-II CHF
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright© 2010 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.
Grant Support
Supported by an educational grant from BIOTRONIK
